-
2
-
-
1842450748
-
The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers
-
Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VH. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res. 2004;21:641-648.
-
(2004)
Pharm Res
, vol.21
, pp. 641-648
-
-
Qaddoumi, M.G.1
Ueda, H.2
Yang, J.3
Davda, J.4
Labhasetwar, V.5
Lee, V.H.6
-
3
-
-
0036020063
-
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen
-
Pignatello R, Claudio B, Piera F, Adriana M, Antonina P, Giovanni P. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Biopharm. 2002;16:53-61.
-
(2002)
Eur J Pharm Biopharm
, vol.16
, pp. 53-61
-
-
Pignatello, R.1
Claudio, B.2
Piera, F.3
Adriana, M.4
Antonina, P.5
Giovanni, P.6
-
4
-
-
4544339611
-
Model of transient drug diffusion across cornea
-
Zhang W, Prausnitz MR, Edwards A. Model of transient drug diffusion across cornea. J Control Rel. 2004;99:241-258.
-
(2004)
J Control Rel
, vol.99
, pp. 241-258
-
-
Zhang, W.1
Prausnitz, M.R.2
Edwards, A.3
-
5
-
-
0031965225
-
Ophthalmic drug delivery systems-Recent advances
-
Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems-Recent advances. Progr Retinal Eye Res. 1998;17:33-58.
-
(1998)
Progr Retinal Eye Res
, vol.17
, pp. 33-58
-
-
Le Bourlais, C.1
Acar, L.2
Zia, H.3
Sado, P.A.4
Needham, T.5
Leverge, R.6
-
6
-
-
0032211587
-
Recent developments in ophthalmic drug delivery
-
Ding S. Recent developments in ophthalmic drug delivery. PSTT. 1998;1:328-335.
-
(1998)
PSTT
, vol.1
, pp. 328-335
-
-
Ding, S.1
-
7
-
-
67349084376
-
Polymeric nanoparticulate system: A potential approach for ocular drug delivery
-
doi:10.1016/j. jconrel.2008.12.018
-
Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK. Polymeric nanoparticulate system: A potential approach for ocular drug delivery. J Control Rel. 2009; doi:10.1016/j. jconrel.2008.12.018
-
(2009)
J Control Rel
-
-
Nagarwal, R.C.1
Kant, S.2
Singh, P.N.3
Maiti, P.4
Pandit, J.K.5
-
8
-
-
33747603004
-
Polymeric materials for ophthalmic drug delivery: Trends and perspectives
-
Barbu E, Verestiuc L, Nevell TG, Tsibouklis J. Polymeric materials for ophthalmic drug delivery: Trends and perspectives. J Mater Chem. 2006;16:3439-3443.
-
(2006)
J Mater Chem
, vol.16
, pp. 3439-3443
-
-
Barbu, E.1
Verestiuc, L.2
Nevell, T.G.3
Tsibouklis, J.4
-
9
-
-
34548658906
-
Ability of poly-L-arginine to enhance drug absorption into aqueous humor and vitreous body after instillation in rabbits
-
Ueda NH, Akimoto M, Natsume H, Morimoto Y. Ability of poly-L-arginine to enhance drug absorption into aqueous humor and vitreous body after instillation in rabbits. Biol Pharm Bull. 2007;30:1768-1772.
-
(2007)
Biol Pharm Bull
, vol.30
, pp. 1768-1772
-
-
Ueda, N.H.1
Akimoto, M.2
Natsume, H.3
Morimoto, Y.4
-
10
-
-
0035999781
-
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
-
Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials. 2002;23:3247-3255.
-
(2002)
Biomaterials
, vol.23
, pp. 3247-3255
-
-
Pignatello, R.1
Bucolo, C.2
Spedalieri, G.3
Maltese, A.4
Puglisi, G.5
-
11
-
-
0028020208
-
Evaluation of pilocarpineloaded albumin particles as drug delivery systems for controlled delivery in the eye. I. in vitro and in vivo characterization
-
Zimmer AK, Serbe H, Kreuter J. Evaluation of pilocarpineloaded albumin particles as drug delivery systems for controlled delivery in the eye. I. In vitro and in vivo characterization. J Control Rel. 1994;32:57-70.
-
(1994)
J Control Rel
, vol.32
, pp. 57-70
-
-
Zimmer, A.K.1
Serbe, H.2
Kreuter, J.3
-
12
-
-
0030841791
-
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
-
DOI 10.1016/S0378-5173(97)00083-5, PII S0378517397000835
-
Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm. 1997;153:41-50. (Pubitemid 27283332)
-
(1997)
International Journal of Pharmaceutics
, vol.153
, Issue.1
, pp. 41-50
-
-
Calvo, P.1
Vila-Jato, J.L.2
Alonso, M.J.3
-
13
-
-
34447254990
-
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
-
Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm. 2007;340:126-133.
-
(2007)
Int J Pharm
, vol.340
, pp. 126-133
-
-
Kassem, M.A.1
Abdel Rahman, A.A.2
Ghorab, M.M.3
Ahmed, M.B.4
Khalil, R.M.5
-
14
-
-
0242351952
-
Cyclosporine A delivery to the eye: A pharmaceutical challenge
-
Lallemand F, Felt-Baeyens O, Besseghir K, Behar- Cohen F, Gurny R. Cyclosporine A delivery to the eye: A pharmaceutical challenge. Eur J Pharm Biopharm. 2003;56:307-318.
-
(2003)
Eur J Pharm Biopharm
, vol.56
, pp. 307-318
-
-
Lallemand, F.1
Felt-Baeyens, O.2
Besseghir, K.3
Behar- Cohen, F.4
Gurny, R.5
-
15
-
-
0036149064
-
Cyclosporine A formulation affects its ocular distribution in rabbits
-
Kuwano M, Ibuki H, Morikawa N, Ota A, Kawashima Y. Cyclosporine A formulation affects its ocular distribution in rabbits. Pharm Res. 2002;19:108-111.
-
(2002)
Pharm Res
, vol.19
, pp. 108-111
-
-
Kuwano, M.1
Ibuki, H.2
Morikawa, N.3
Ota, A.4
Kawashima, Y.5
-
16
-
-
0027170712
-
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders
-
Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993;46:953-1040.
-
(1993)
Drugs
, vol.46
, pp. 953-1040
-
-
Faulds, D.1
Goa, K.L.2
Benfield, P.3
-
17
-
-
33747795904
-
Disease, destination, dose, and delivery aspects of cyclosporin: The state of the art
-
Italia JL, Bhardwaj V, Kumar MN. Disease, destination, dose, and delivery aspects of cyclosporin: The state of the art. Drug Discov Today. 2006;11:846-854.
-
(2006)
Drug Discov Today
, vol.11
, pp. 846-854
-
-
Italia, J.L.1
Bhardwaj, V.2
Kumar, M.N.3
-
18
-
-
0029917195
-
Polyester nanocapsules as a new topical ocular delivery system for cyclosporine A
-
Calvo P, Sánchez A, Martínez J, López MI, Calonge M, Pastor JC, Alonso MJ. Polyester nanocapsules as a new topical ocular delivery system for cyclosporine A. Pharm Res. 1996;13:311-315.
-
(1996)
Pharm Res
, vol.13
, pp. 311-315
-
-
Calvo, P.1
Sánchez, A.2
Martínez, J.3
López, M.I.4
Calonge, M.5
Pastor, J.C.6
Alonso, M.J.7
-
19
-
-
0029127757
-
Increased ocular corneal uptake of drugs using poly-ε-caprolactone nanocapsules and nanoemulsions
-
Alonso MJ, Calvo P, Vila-Jato JL, López MI, Llorente J, Pastor JC. Increased ocular corneal uptake of drugs using poly-ε-caprolactone nanocapsules and nanoemulsions. In: Proc Int Symp Control Rel Bioact Mater. 1995;22.
-
(1995)
Proc Int Symp Control Rel Bioact Mater
, pp. 22
-
-
Alonso, M.J.1
Calvo, P.2
Vila-Jato, J.L.3
López, M.I.4
Llorente, J.5
Pastor, J.C.6
-
20
-
-
0030860843
-
Effect of cyclosporine A formulations on bovine corneal absorption: Ex vivo study
-
Le Bourlais C, Chevarme F, Turlin B, Acar L, Zia H, Sado PA, Necdham TE, Leverge R. Effect of cyclosporine A formulations on bovine corneal absorption: Ex vivo study. J Microencapsul. 1997;14:457-467.
-
(1997)
J Microencapsul
, vol.14
, pp. 457-467
-
-
Le Bourlais, C.1
Chevarme, F.2
Turlin, B.3
Acar, L.4
Zia, H.5
Sado, P.A.6
Necdham, T.E.7
Leverge, R.8
-
21
-
-
0038032150
-
Solid lipid nanoparticles (SLN) for controlled drug delivery: A review of the state of the art
-
Müller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery: A review of the state of the art. Eur J Pharm Biopharm. 2000;50:161-177.
-
(2000)
Eur J Pharm Biopharm
, vol.50
, pp. 161-177
-
-
Müller, R.H.1
Mader, K.2
Gohla, S.3
-
22
-
-
0035946615
-
Solid lipid nanoparticles: Production, characterization, and applications
-
Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization, and applications. Adv Drug Deliv Rev. 2001;47:165-196.
-
(2001)
Adv Drug Deliv Rev
, vol.47
, pp. 165-196
-
-
Mehnert, W.1
Mader, K.2
-
23
-
-
0037093721
-
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
-
DOI 10.1016/S0378-5173(02)00080-7, PII S0378517302000807
-
Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm. 2002;238:241-245. (Pubitemid 34457892)
-
(2002)
International Journal of Pharmaceutics
, vol.238
, Issue.1-2
, pp. 241-245
-
-
Cavalli, R.1
Gasco, M.R.2
Chetoni, P.3
Burgalassi, S.4
Saettone, M.F.5
-
24
-
-
0028897685
-
Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair
-
Cavalli R, Morel S, Gasco MR, Chetoni P, Saettone MF. Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair. Int J Pharm. 1995;117:243-246.
-
(1995)
Int J Pharm
, vol.117
, pp. 243-246
-
-
Cavalli, R.1
Morel, S.2
Gasco, M.R.3
Chetoni, P.4
Saettone, M.F.5
-
25
-
-
0035109447
-
Encapsulation of retinoids in solid lipid nanoparticles (SLN)
-
Jenning V, Gohla S. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul. 2001;18:149-158.
-
(2001)
J Microencapsul
, vol.18
, pp. 149-158
-
-
Jenning, V.1
Gohla, S.2
-
27
-
-
0037173520
-
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN)
-
DOI 10.1016/S0378-5173(02)00268-5, PII S0378517302002685
-
Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm. 2002;241:341-344. (Pubitemid 34718035)
-
(2002)
International Journal of Pharmaceutics
, vol.241
, Issue.2
, pp. 341-344
-
-
Ugazio, E.1
Cavalli, R.2
Gasco, M.R.3
-
28
-
-
0031584680
-
High performance liquid chromatography cyclosporin A and its oral solution
-
Husek A. High performance liquid chromatography cyclosporin A and its oral solution. J Chrom A. 1997;759:217-224.
-
(1997)
J Chrom A
, vol.759
, pp. 217-224
-
-
Husek, A.1
-
29
-
-
0037073656
-
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs
-
Baeyens V, Felt-Baeyens O, Rougier S, Pheulpin S, Boisrame B, Gurny R. Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs. J Control Rel. 2002;85:163-168.
-
(2002)
J Control Rel
, vol.85
, pp. 163-168
-
-
Baeyens, V.1
Felt-Baeyens, O.2
Rougier, S.3
Pheulpin, S.4
Boisrame, B.5
Gurny, R.6
-
30
-
-
40349097794
-
Alginate and chitosan particles as drug delivery system for cell therapy
-
Ciofani G, Rafa V, Menciassi A, Dario P. Alginate and chitosan particles as drug delivery system for cell therapy. Biomed Microdevices. 2008;10:131-140.
-
(2008)
Biomed Microdevices
, vol.10
, pp. 131-140
-
-
Ciofani, G.1
Rafa, V.2
Menciassi, A.3
Dario, P.4
-
31
-
-
0032871052
-
Pectin microspheres as ophthalmic carriers for piroxicam: Evaluation in vitro and in vivo in albino rabbits
-
Giunchedi P, Conte U, Chetoni P, Saettone MF. Pectin microspheres as ophthalmic carriers for piroxicam: Evaluation in vitro and in vivo in albino rabbits. Eur J Pharm Sci. 1999;9:1-7.
-
(1999)
Eur J Pharm Sci
, vol.9
, pp. 1-7
-
-
Giunchedi, P.1
Conte, U.2
Chetoni, P.3
Saettone, M.F.4
-
32
-
-
0036779689
-
Comparative permeability of human and rabbit corneas to cyclosporin and tritiated water
-
Van Der Bijl P, Engelbrecht AH, Van Eyk AD, Meyer D. Comparative permeability of human and rabbit corneas to cyclosporin and tritiated water. J Ocular Pharm Ther. 2002;18:419-427.
-
(2002)
J Ocular Pharm Ther
, vol.18
, pp. 419-427
-
-
Van Der Bijl, P.1
Engelbrecht, A.H.2
Van Eyk, A.D.3
Meyer, D.4
-
33
-
-
0034977298
-
Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles
-
Yeh MK, Tung SM, Lu DW, Chen JL, Chiang CH. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles. J Microencapsul. 2001;18:507-519.
-
(2001)
J Microencapsul
, vol.18
, pp. 507-519
-
-
Yeh, M.K.1
Tung, S.M.2
Lu, D.W.3
Chen, J.L.4
Chiang, C.H.5
-
34
-
-
33749657983
-
Preparation of vancomycin microparticles: Importance of preparation parameters
-
Hachicha W, Kodjikian L, Fessi H. Preparation of vancomycin microparticles: Importance of preparation parameters. Int J Pharm. 2006;324:176-184.
-
(2006)
Int J Pharm
, vol.324
, pp. 176-184
-
-
Hachicha, W.1
Kodjikian, L.2
Fessi, H.3
-
35
-
-
0033179091
-
Assessing ocular drug delivery with lachrimal scintigraphy
-
Wilson CG. Assessing ocular drug delivery with lachrimal scintigraphy. PSTT. 1999;2:321-326.
-
(1999)
PSTT
, vol.2
, pp. 321-326
-
-
Wilson, C.G.1
-
36
-
-
33749124756
-
Cyclosporine-loaded microspheres for treatment of uveitis: In vitro characterization and in vivo pharmacokinetic study
-
He Y, Liu Y, Liu Y, Wang J, Zhang X, Lu W, Ma Z, Zhu X, Zhang Q. Cyclosporine-loaded microspheres for treatment of uveitis: In vitro characterization and in vivo pharmacokinetic study. IOVS. 2006;47:9.
-
(2006)
IOVS
, vol.47
, pp. 9
-
-
He, Y.1
Liu, Y.2
Liu, Y.3
Wang, J.4
Zhang, X.5
Lu, W.6
Ma, Z.7
Zhu, X.8
Zhang, Q.9
-
37
-
-
33645999705
-
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism, and in vivo tolerance
-
Salamanca AE, Diebold Y, Calonge M, Garcia-Vazquez C, Callejo S, Vila A, Alonso MJ. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism, and in vivo tolerance. IOVS. 2006;47:4.
-
(2006)
IOVS
, vol.47
, pp. 4
-
-
Salamanca, A.E.1
Diebold, Y.2
Calonge, M.3
Garcia-Vazquez, C.4
Callejo, S.5
Vila, A.6
Alonso, M.J.7
-
38
-
-
0033058028
-
Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs
-
Acheampong AA, Shackleton M, Tang-Liu DD, Ding S, Stern ME, Decker R. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. Curr Eye Res. 1999;18:91-103.
-
(1999)
Curr Eye Res
, vol.18
, pp. 91-103
-
-
Acheampong, A.A.1
Shackleton, M.2
Tang-Liu, D.D.3
Ding, S.4
Stern, M.E.5
Decker, R.6
-
39
-
-
53949111819
-
Cyclosporine A-loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity
-
Gokce EH, Sandri G, Bonferoni MC, Rossi S, Ferrari F, Güneri T, Caramella C. Cyclosporine A-loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm. 2008;364:76-86.
-
(2008)
Int J Pharm
, vol.364
, pp. 76-86
-
-
Gokce, E.H.1
Sandri, G.2
Bonferoni, M.C.3
Rossi, S.4
Ferrari, F.5
Güneri, T.6
Caramella, C.7
-
40
-
-
0034731605
-
Lipase protein engineering
-
Svendsen A. Lipase protein engineering. Biochim Biophys Acta. 2000;1543:223-228.
-
(2000)
Biochim Biophys Acta
, vol.1543
, pp. 223-228
-
-
Svendsen, A.1
-
41
-
-
0036981659
-
Retinal pigment epithelial acid lipase activity and lipoprotein receptors: Effects of dietary omega-3 fatty acids
-
Elner VM. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: Effects of dietary omega-3 fatty acids. Trans Am Ophthalmol Soc. 2002;100:301-338.
-
(2002)
Trans Am Ophthalmol Soc
, vol.100
, pp. 301-338
-
-
Elner, V.M.1
-
42
-
-
0025937924
-
Studies on the transport pathway of PBCA nanoparticles in ocular tissues
-
Zimmer A, Kreuter J, Robinson JR. Studies on the transport pathway of PBCA nanoparticles in ocular tissues. J Microencapsul. 1991;8:497-504.
-
(1991)
J Microencapsul
, vol.8
, pp. 497-504
-
-
Zimmer, A.1
Kreuter, J.2
Robinson, J.R.3
-
43
-
-
0026475060
-
Effect of cyclosporin on plasma lipoprotein lipase activity in rats
-
López-Miranda J, Pérez-Jiménez F, Gómez-Gerique JA, Espino-Montoro A, Hidalgo-Rojas L, Pedreño J, Jiménez- Perepérez JA. Effect of cyclosporin on plasma lipoprotein lipase activity in rats. Clin Biochem. 1992;25:387-394.
-
(1992)
Clin Biochem
, vol.25
, pp. 387-394
-
-
López-Miranda, J.1
Pérez-Jiménez, F.2
Gómez-Gerique, J.A.3
Espino-Montoro, A.4
Hidalgo-Rojas, L.5
Pedreño, J.6
Jiménez- Perepérez, J.A.7
-
44
-
-
41349106751
-
Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct
-
Atama AA, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm. 2008;355:307-313.
-
(2008)
Int J Pharm
, vol.355
, pp. 307-313
-
-
Atama, A.A.1
Reichl, S.2
Müller-Goymann, C.C.3
-
45
-
-
26644437438
-
The use of mucoadhesive polymers in ocular drug delivery
-
Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57:1595-1639.
-
(2005)
Adv Drug Deliv Rev
, vol.57
, pp. 1595-1639
-
-
Ludwig, A.1
-
46
-
-
0034045780
-
Biopharmaceutical considerations in topical ocular drug delivery
-
Davies NM. Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharm Physiol. 2000;27:558-562.
-
(2000)
Clin Exp Pharm Physiol
, vol.27
, pp. 558-562
-
-
Davies, N.M.1
-
47
-
-
33747125838
-
Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems
-
Bodor N, Buchwald P. Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems. AAPS PharmSciTech. 2005;7:E820-833.
-
(2005)
AAPS PharmSciTech
, vol.7
-
-
Bodor, N.1
Buchwald, P.2
-
48
-
-
10744229446
-
Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model
-
Toropainen E, Ranta VP, Vellonen KS, Palmgrén J, Talvitie A, Laavola M, Suhonen P, Hämäläinen KM, Auriola S, Urtti A. Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. Eur J Pharm Biopharm. 2003;20:99-106.
-
(2003)
Eur J Pharm Biopharm
, vol.20
, pp. 99-106
-
-
Toropainen, E.1
Ranta, V.P.2
Vellonen, K.S.3
Palmgrén, J.4
Talvitie, A.5
Laavola, M.6
Suhonen, P.7
Hämäläinen, K.M.8
Auriola, S.9
Urtti, A.10
-
49
-
-
0026666843
-
The transport barrier of epithelia: A comparative study on membrane permeability and charge selectivity in the rabbit
-
Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JKM. The transport barrier of epithelia: A comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res. 1992;9:1029-1034.
-
(1992)
Pharm Res
, vol.9
, pp. 1029-1034
-
-
Rojanasakul, Y.1
Wang, L.Y.2
Bhat, M.3
Glover, D.D.4
Malanga, C.J.5
Ma, J.K.M.6
-
50
-
-
0035859983
-
Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A
-
De Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001;224:159-168.
-
(2001)
Int J Pharm
, vol.224
, pp. 159-168
-
-
De Campos, A.M.1
Sanchez, A.2
Alonso, M.J.3
-
51
-
-
0038683266
-
Physical and thermal characterization of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets
-
Hamdani J, Moes AJ, Amighi K. Physical and thermal characterization of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int J Pharm. 2003;260:47-57.
-
(2003)
Int J Pharm
, vol.260
, pp. 47-57
-
-
Hamdani, J.1
Moes, A.J.2
Amighi, K.3
-
52
-
-
36248978068
-
Nanostructured lipid carriers as novel carrier for sunscreen formulations
-
Xia Q, Saupe A, Müller RH, Souto EB. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci. 2007;29:473-482.
-
(2007)
Int J Cosmet Sci
, vol.29
, pp. 473-482
-
-
Xia, Q.1
Saupe, A.2
Müller, R.H.3
Souto, E.B.4
-
53
-
-
0345497069
-
Evaluation of primary ocular irritation: Alternatives to the Draize test
-
Reddy IK, ed. Lancaster, PA: Technomic Publishing
-
Hutak CM, Jacaruso RB. Evaluation of primary ocular irritation: Alternatives to the Draize test. In: Reddy IK, ed. Ocular Therapeutics and Drug Delivery. Lancaster, PA: Technomic Publishing; 1996: 489-525.
-
(1996)
Ocular Therapeutics and Drug Delivery
, pp. 489-525
-
-
Hutak, C.M.1
Jacaruso, R.B.2
-
54
-
-
0021267773
-
Cyclosporin: Experience with therapeutic monitoring
-
Bowers LD, Canafax DM. Cyclosporin: Experience with therapeutic monitoring. Ther Drug Monit. 1984;6:142-147.
-
(1984)
Ther Drug Monit
, vol.6
, pp. 142-147
-
-
Bowers, L.D.1
Canafax, D.M.2
|